Maintaining Stable Business Operations and Product Supply Through Infection Prevention Measures
First written in FY2020. 6 of 7 entries say "Restated". Latest entry: FY2022-Q2.
The whole theme swung hardest in 2026: 1 of 12 companies on the "Worse" side.
108 other companies' latest entry also says "Restated".
- FY2022-Q2RestatedAnnual report
「Under these circumstances, while working to prevent infection with the novel coronavirus, the Company continued to improve production efficiency, optimize product inventory levels, reduce various costs and pursue stable sales.」
The company continues its policy of improving production efficiency, optimizing inventory levels, reducing costs and maintaining stable sales while taking measures to prevent COVID-19 infections. - FY2022-Q1RestatedAnnual report
「Under these circumstances, while working to prevent infection with the novel coronavirus, the Company continued to improve production efficiency, optimize product inventory levels, reduce various costs and pursue stable sales.」
The company continues its policy of improving production efficiency, optimizing inventory levels, reducing costs and maintaining stable sales while taking measures to prevent COVID-19 infections. - FY2021RestatedAnnual report
「While working to prevent COVID-19 infections, we continued to improve production efficiency, optimize product inventory levels, reduce various costs and maintain stable sales.」
The company continues its policy of improving production efficiency, optimizing inventory levels, reducing costs and maintaining stable sales while taking infection-prevention measures. - FY2021-Q3RestatedAnnual report
「Under these circumstances, while working to prevent infection with the novel coronavirus, the Company continued to improve production efficiency, optimize product inventory levels, reduce various costs and pursue stable sales.」
Reconfirms its efforts to maintain stable operations and continue sales while taking measures to prevent COVID-19 infections. - FY2021-Q2RestatedAnnual report
「Under these circumstances, while working to prevent infection with the novel coronavirus, the Company continued to improve production efficiency, optimize product inventory levels, reduce various costs and pursue stable sales.」
Reconfirms its efforts to maintain stable operations and continue sales while taking measures to prevent COVID-19 infections. - FY2021-Q1RestatedAnnual report
「Under these circumstances, while working to prevent infection with the novel coronavirus, the Company continued to improve production efficiency, optimize product inventory levels, reduce various costs and pursue stable sales.」
States that the company worked to maintain stable operations and continue sales while taking measures to prevent COVID-19 infections. - FY2020First statedAnnual report
「To address these risks, the Company is working to reduce them by implementing infection-prevention measures, including thorough employee health monitoring such as temperature checks, restricting access to manufacturing areas by personnel other than manufacturing workers, and allowing some employees to work from home or use staggered working hours.」
As measures to address COVID-19, the Company described temperature checks, restrictions on access to manufacturing areas, working from home, and staggered working hours for the first time.